What is the translation of " WERE RANDOMIZED " in Croatian?

• randomizirano je
• su bili randomizirani
• bilo randomizirano
• su randomizirana

Examples of using Were randomized in English and their translations into Croatian

Patients were randomized into two groups.
Bolesnici su bili randomizirani u dvije skupine.

A total of 154 patients(ECOG Performance Status 0 or 1) were randomized.
Ukupno su randomizirana 154 bolesnika ECOG funkcionalni status 0 ili 1.

Patients were randomized(1:1:1) to 1 of 3 treatment arms.
Bolesnici su bili randomizirani(1:1:1) u 1 od 3 terapijske skupine.

A total of 393 patients(mean age 63.2 years; 65% male patients) were randomized.
Randomizirano je ukupno 393 bolesnika srednja vrijednost dobi je 63, 2 godine; 65% bolesnika muškog spola.

A total of 350 patients were randomized randomization ratio 1:1.
Ukupno 350 bolesnika bilo je randomizirano omjer randomizacije 1:1.

Primary prophylactic G-CSF was made mandatory in TAC arm after 230 patients were randomized.
Primarna G- CSF profilaksa uvedena je kao obavezna u TAC skupini nakon što je randomizirano 230 bolesnika.

Patients were randomized into two groups of fifteen subjects each.
Bolesnici su bili randomizirani u dvije skupine od petnaest ispitanika.

In the pooled RE-COVER and RE-COVER II studies, a total of 5,153 patients were randomized and 5,107 were treated.
U združenim ispitivanjima RE-COVER i RE-COVER II, ukupno je randomizirano 5 153 bolesnika, a 5 107 ih je liječeno.

Patients were randomized in a 1:1:1 ratio to one of 3 treatment arms.
Bolesnici su randomizirani u omjeru 1:1:1 u jednu od 3 terapijske skupine.

A total of 1,006 patients with KPS≥60 were randomized to the following treatment groups.
Ukupno 1006 bolesnika s KPS> 60 randomizirani su prema liječenju u sljedeće skupine.

Patients were randomized in a 3:2 ratio to treatment with Ofev 150 mg or placebo twice daily for 52 weeks.
Bolesnici su bili randomizirani u omjeru 3:2 za liječenje Ofevom 150 mg ili placebom dvaput dnevno u trajanju od 52 tjedna.

Note: Presentation of alternate listings were randomized evenly and consistently throughout the field.
Napomena: prezentacija naizmjeničnih profila ravnomjerno je nasumično i dosljedno raspoređena u polju.

Patients were randomized in a 1:1 fashion to treatment with either bosutinib 500 mg once daily or imatinib 400 mg once daily.
Bolesnici su randomizirani na način 1:1 za liječenje ili bosutinibom 500 mg jedanput dnevno ili imatinibom 400 mg jedanput dnevno.

A number of 176 patients with CLL were randomized into the following two treatment groups.
Ukupno je 176 bolesnika s KLL-om bilo randomizirano u sljedeće dvije terapijske skupine.

Patients were randomized to receive velaglucerase alfa at a dose of either 45 Units/kg(N=13) or 60 Units/kg(N=12) every other week.
Bolesnici su bili randomizirani na primanje velagluceraze alfa u dozi od 45 jedinica/kg(N=13) ili 60 jedinica/kg(N=12) svaki drugi tjedan.

The overall trial design was identical among both stages and patients were randomized into the following two treatment groups.
Cjelokupan dizajn ispitivanja bio je identičan u oba dijela, a bolesnici su bili randomizirani u sljedeće dvije terapijske skupine.

Study I patients were randomized to receive abatacept 2 or 10 mg/kg or placebo for 12 months.
U Ispitivanju I bolesnici su randomizirani da tijekom 12 mjeseci primaju abatacept u dozi od 2 ili 10 mg/kg, odnosno placebo.

In this study, 501 patients, with locally advanced SCCHN, and a WHO performance status of 0 or 1, were randomized to one of two arms.
U ovom je ispitivanju, u dvije skupine bio randomiziran 501 bolesnik s lokalno uznapredovalim SCCHN, funkcionalnog statusa 0 ili 1 prema SZO ljestvici.

A total of 2,866 patients were randomized and 2,856 patients were treated.
Ukupno je bilo randomizirano 2 866 bolesnika, a 2 856 bolesnika je bilo liječeno.

In this study, 358 patients with inoperable locally advanced SCCHN, and WHO perfomance status 0 or 1, were randomized to one of two treatment arms.
U ovoj je studiji 358 bolesnika s inoperabilnim, lokalno uznapredovalim SCCHN, WHO izvedbenog statusa 0 ili 1, bilo randomizirano u jednu od dvije liječene skupine.

Eligible patients were randomized(1:1:1:1) to placebo or one of three fixed levodopa/carbidopa doses of 145 mg/36.25 mg.
Podobni bolesnici randomizirani su(1:1:1:1) u placebo ili u jednu od tri fiksne doze levodope/karbidope od.

In a randomized, open-label study(SP825) in patients with early stage Parkinson's disease, 25 patients were randomized to rotigotine treatment and 26 to ropinirole.
U randomiziranom, otvorenom ispitivanju(SP825) u bolesnika u ranom stadiju Parkinsonove bolesti 25 bolesnika randomizirano je za liječenje rotigotinom, a njih 26 za liječenje ropinirolom.

A total of 618 patients were randomized to receive 7 mg(n=205) or 14 mg(n=216) of teriflunomide or placebo n=197.
Ukupno 618 bolesnika randomizirano je kako bi primalo 7 mg(n=205) ili 14 mg(n=216) teriflunomida ili placebo n=197.

A total of 180 subjects with alpha1-proteinase inhibitor deficiency characterized by a serum alpha1-proteinase inhibitor level< 11 μM(i.e.< 50 mg/dL as determined by nephelometry) and clinical evidence of emphysema, were randomized to receive a weekly 60 mg/ kg bw intravenous dose of either Respreeza(93 subjects) or placebo(87 subjects) for up to 24 months.
Ukupno je 180 ispitanika s nedostatkom inhibitora alfa1-proteinaze s razinom inhibitora alfa1-proteinaze u serumu< 11 μM(tj.< 50 mg/dl određeno nefelometrijom) i kliničkim dokazima emfizema bilo randomizirano kako bi primali tjednu intravensku dozu od 60 mg/kg TT Respreeze(93 ispitanika) ili placebo(87 ispitanika) tijekom najviše 24 mjeseca.

Patients were randomized(2:1) to receive blinded treatment with entecavir 0.015 mg/kg up to 0.5 mg/day(N 120) or placebo N 60.
Bolesnici su randomizirani(2:1) da primaju slijepo liječenje entekavirom u dozi od 0, 015 mg/kg do najviše 0, 5 mg/dan(N 120) ili placebo N 60.

For renally impaired subjects who were randomized to allopurinol, the dose was capped at 100 mg QD.
Kod ispitanika s oštećenom funkcijom bubrega koji su randomizirani u skupinu liječenu alopurinolom, najviša doza bila je 100 mg jednom dnevno.

Study V patients were randomized to receive this same fixed dose of abatacept or 3 mg/kg infliximab or placebo for 6 months.
U Ispitivanju V bolesnici su randomizirani tako da su tijekom 6 mjeseci primali abatacept u istoj toj fiksnoj dozi, infliksimab u dozi od 3 mg/kg ili placebo.

Seven hundred sixty(760) patients were randomized: ADENURIC 80 mg QD(n=256), ADENURIC 120 mg QD(n=251), or allopurinol 300 mg QD n=253.
Sedamsto šezdeset(760) bolesnika je randomizirano te su primali: ADENURIC 80 mg jednom dnevno(n 256), ADENURIC 120 mg jednom dnevno(n 251), ili alopurinol 300 mg jednom dnevno n 253.

Overall, 6068 patients were randomized 1:1 to either placebo or lixisenatide 20 mcg following a starting dose of 10 mcg during the first 2 weeks.
Svekupno, 6068 bolesnika bilo je randomizirano 1:1 na placebo ili liksisenatid 20 µg nakon početne doze od 10 µg tijekom prva 2 tjedna.

Subjects were randomized in a 2:1 ratio and stratified based on cirrhosis/fibrosis and baseline HCV-RNA< 800,000 IU/mL vs.≥ 800,000 IU/mL.
Ispitanici su randomizirani u omjeru 2:1 i stratificirani na temelju ciroze/fibroze i početne vrijednosti HCV-RNK< 800 000 IU/ml naspram ≥ 800 000 IU/ml.